Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency Using Peripheral Blood and EFS ADA Vector

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency Using Peripheral Blood and EFS ADA Vector	severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency	Active, not recruiting	Phase 1 / Phase 2	2026-08-20		NCT05432310

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of California, Los Angeles	355

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of California, Los Angeles (UCLA)	Los Angeles	United States	14

Clinical trials